Cargando…

Burden of melioidosis in India and South Asia: Challenges and ways forward

Melioidosis is caused by the environmental bacterium Burkholderia pseudomallei. South Asia is estimated to have 44% of the global disease burden. Among South Asian countries, Bangladesh and Sri Lanka are considered endemic for melioidosis; a few cases have been reported from Nepal, and a few importe...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohapatra, Prasanta R, Mishra, Baijayantimala
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10306050/
https://www.ncbi.nlm.nih.gov/pubmed/37383295
http://dx.doi.org/10.1016/j.lansea.2022.03.004
_version_ 1785065857578172416
author Mohapatra, Prasanta R
Mishra, Baijayantimala
author_facet Mohapatra, Prasanta R
Mishra, Baijayantimala
author_sort Mohapatra, Prasanta R
collection PubMed
description Melioidosis is caused by the environmental bacterium Burkholderia pseudomallei. South Asia is estimated to have 44% of the global disease burden. Among South Asian countries, Bangladesh and Sri Lanka are considered endemic for melioidosis; a few cases have been reported from Nepal, and a few imported cases from Pakistan have also been reported. India has experienced an increase in numbers of melioidosis cases in the recent years. The bacteria is inherently present in the soil and enters the human body via skin abrasions, inhalation, or ingestion. As clinicians are often ignorant about the similar characteristics of this disease and several other common tropical diseases, it causes a major delay in the timely diagnosis and management. The organism is easily mistaken as Pseudomonas spp in microbiology laboratories and may be dismissed as a common laboratory contaminant. The poor diagnostic sensitivity of blood culture also leads to missed diagnosis. Hence, both clinical ignorance and missed laboratory diagnosis have misrepresented melioidosis as a rare entity. The key preventive interventions are avoiding contact with loose and muddy soils of meliodosis-endemic areas, and provision of safe drinking water. The present article describes the various possible attributes for melioidosis underdiagnosis and the challenges of improving the diagnosis in conjunction with viable solutions. FUNDING: None.
format Online
Article
Text
id pubmed-10306050
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-103060502023-06-28 Burden of melioidosis in India and South Asia: Challenges and ways forward Mohapatra, Prasanta R Mishra, Baijayantimala Lancet Reg Health Southeast Asia Review Melioidosis is caused by the environmental bacterium Burkholderia pseudomallei. South Asia is estimated to have 44% of the global disease burden. Among South Asian countries, Bangladesh and Sri Lanka are considered endemic for melioidosis; a few cases have been reported from Nepal, and a few imported cases from Pakistan have also been reported. India has experienced an increase in numbers of melioidosis cases in the recent years. The bacteria is inherently present in the soil and enters the human body via skin abrasions, inhalation, or ingestion. As clinicians are often ignorant about the similar characteristics of this disease and several other common tropical diseases, it causes a major delay in the timely diagnosis and management. The organism is easily mistaken as Pseudomonas spp in microbiology laboratories and may be dismissed as a common laboratory contaminant. The poor diagnostic sensitivity of blood culture also leads to missed diagnosis. Hence, both clinical ignorance and missed laboratory diagnosis have misrepresented melioidosis as a rare entity. The key preventive interventions are avoiding contact with loose and muddy soils of meliodosis-endemic areas, and provision of safe drinking water. The present article describes the various possible attributes for melioidosis underdiagnosis and the challenges of improving the diagnosis in conjunction with viable solutions. FUNDING: None. Elsevier 2022-05-05 /pmc/articles/PMC10306050/ /pubmed/37383295 http://dx.doi.org/10.1016/j.lansea.2022.03.004 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Mohapatra, Prasanta R
Mishra, Baijayantimala
Burden of melioidosis in India and South Asia: Challenges and ways forward
title Burden of melioidosis in India and South Asia: Challenges and ways forward
title_full Burden of melioidosis in India and South Asia: Challenges and ways forward
title_fullStr Burden of melioidosis in India and South Asia: Challenges and ways forward
title_full_unstemmed Burden of melioidosis in India and South Asia: Challenges and ways forward
title_short Burden of melioidosis in India and South Asia: Challenges and ways forward
title_sort burden of melioidosis in india and south asia: challenges and ways forward
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10306050/
https://www.ncbi.nlm.nih.gov/pubmed/37383295
http://dx.doi.org/10.1016/j.lansea.2022.03.004
work_keys_str_mv AT mohapatraprasantar burdenofmelioidosisinindiaandsouthasiachallengesandwaysforward
AT mishrabaijayantimala burdenofmelioidosisinindiaandsouthasiachallengesandwaysforward